Abbott realtime MTB assay for detecting Mycobacterium tuberculosis complex in respiratory specimens: a cost-benefit analysis
- PMID: 38958810
- DOI: 10.1007/s10096-024-04880-1
Abbott realtime MTB assay for detecting Mycobacterium tuberculosis complex in respiratory specimens: a cost-benefit analysis
Abstract
Purpose: Molecular screening for Mycobacterium tuberculosis (MTB) can lead to rapid empirical treatment inception and reduce hospitalization time and complementary diagnostic tests. However, in low-prevalence settings, the cost-benefit balance remains controversial due to the high cost.
Methods: We used a Markov model to perform an economic analysis to evaluate the profit after implementing molecular MTB screening (Period B) compared with conventional culture testing (Period A) in respiratory samples from 7,452 consecutive subjects with presumed tuberculosis (TB).
Results: The proportion of positivity was comparable between both periods (P > 0.05), with a total of 2.16 and 1.78 samples/patient requested in periods A and B, respectively (P < 0.001). The mean length of hospital stay was 8.66 days (95%CI: 7.63-9.70) in Period B and 11.51 days (95%CI: 10.15-12.87) in Period A (P = 0.001). The healthcare costs associated with diagnosing patients with presumed TB were reduced by €717.95 per patient with PCR screening. The probability of remaining hospitalized and the need for a greater number of outpatient specialty care visits were the variables with the most weight in the model.
Conclusion: Employing PCR as an MTB screening method in a low-prevalence setting may increase the profits to the system.
Keywords: Mycobacterium tuberculosis; Cost-benefit; Economic evaluation; Markov model; Molecular screening.
© 2024. The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature.
References
-
- Global tuberculosis report 2023 (2023) Licence: CC BY-NC-SA 3.0 IGO. World Health Organization, Geneva
-
- Lewinsohn DM, Leonard MK, LoBue PA, Cohn DL, Daley CL, Desmond E, Keane J, Lewinsohn DA, Loeffler AM, Mazurek GH, O’Brien RJ, Pai M, Richeldi L, Salfinger M, Shinnick TM, Sterling TR, Warshauer DM, Woods GL (2017) Official American Thoracic Society/Infectious Diseases Society of America/Centers for Disease Control and Prevention Clinical Practice Guidelines: Diagnosis of Tuberculosis in Adults and Children. Clin Infect Dis. ;64(2):111–115. https://doi.org/10.1093/cid/ciw778 . PMID: 28052967; PMCID: PMC5504475.
-
- WHO consolidated guidelines on tuberculosis (2021) Module 3: diagnosis - rapid diagnostics for tuberculosis detection, 2021 update. World Health Organization, Geneva. Licence: CC BY-NC-SA 3.0 IGO
-
- Lohmann EM, Koster BF, le Cessie S, Kamst-van Agterveld MP, van Soolingen D, Arend SM (2012) Grading of a positive sputum smear and the risk of Mycobacterium tuberculosis transmission. Int J Tuberc Lung Dis 16(11):1477–1484. https://doi.org/10.5588/ijtld.12.0129 - DOI - PubMed
MeSH terms
LinkOut - more resources
Full Text Sources
